No diffuse answers: The impact of vitreous sampling in unilateral pediatric leukocoria
Author: Eduardo Viteri (Ecuador)
Co-authors: Juan David Arias, M. Margarita Parra, Isabel Bolivar
Purpose
To highlight the importance of ocular pathology in the management of atypical pediatric cases and educate about uncommon presentations of retinoblastoma that are life threatening.
Setting/Venue
Tertiary referral center with a high volume vitreoretinal surgery department and access to an ocular pathology laboratory.
Methods
A brief clinical description of an atypical presentation of a suspected uveitic pediatric cataract with non conclusive imaging is first described. Surgical video with narrated technique is demonstrated followed by definitive histopathologic and immunohistochemistry correlations that inform therapeutic decisions.
Results
A 10 year-old boy developed leukocoria over a 3 month period due to a rapidly advancing cataract that precludes fundus exam and was associated with granulomatous panuveitis on his right eye. Contralateral eye exam was normal, systemic infectious serology exams were negative, ocular ultrasound imaging showed no calcified masses and orbit MRI was within normal limits. Lensectomy was performed but severe vitritis prohibited IOL implantation or clear fundus examination. He was subsequently referred to our ocular oncology consult due to this atypical presentation with a presumed diagnosis of COATS disease or retinoblastoma. Surgical management with diagnostic pars plana vitrectomy including aqueous and vitreous humor biopsy allowed histopathology and immunohistochemical analysis. Results were compatible with diffuse retinoblastoma and immediate enucleation ensued followed by systemic chemotherapy.
Conlusions
Unilateral leukocoria and uveitis in pediatric patients are high risk scenarios and requiere oncologic work up. In atypical presentations the need for definitive diagnosis outweighs the risk of local or systemic extension and allows life preserving treatment. Immunohistochemistry was key to reach a diffuse retinoblastoma diagnosis which is often overlooked and portrays a worse prognosis.
Financial Disclosure
Co-author Juan David Arias is a consultant for TOPCON